Fig. 3
Pooled pCR outcome of TP-treated Asian breast cancer patients according to molecular subtypes. Forest plots describing the random effect ORs and 95% CIs from studies assessing the association of pCR outcome in NAC TP-treated Asian breast cancer patients between (A) HER2E and luminal-like; (B) HER2E and luminal A; (C) HER2E and luminal B; (D) HER2E and luminal, combined; (E) Luminal B and luminal A; (F) TNBC and luminal A; (G) TNBC and luminal B. I2 and p-value for X2 of heterogeneity are reported for each group analysis